News Chart Lotus Pharmaceutical Co., Ltd.

Equities

1795

TW0001795003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 2025-12-05			5-day change	1st Jan Change
297.50 ^TWD	-0.17%		-6.30%	+10.39%

12-01	Lenz Therapeutics, Lotus Pharmaceutical Say New Drug Application for Presbyopia Treatment Submitted in South Korea	MT
12-01	Enz Therapeutics submits NDA for LNZ100 (Vizz) in South Korea to treat presbyopia	RE

b8925d3bcd3eb59b0db97301edbd30d.HnMJmDLA12Mo7zFYZPv4jRMjsc2NyrvVoIz1p36E6TA.fQVv0h-YjTR-3FM_Kc-M9Ctm1bq1rO7t2fW4ignAsXp4N3D2S4iVThjfQg~5550125a4ea3bafb36c75e78d84a83e5